Viewing Study NCT03082833


Ignite Creation Date: 2025-12-25 @ 2:59 AM
Ignite Modification Date: 2026-03-11 @ 12:56 AM
Study NCT ID: NCT03082833
Status: TERMINATED
Last Update Posted: 2019-05-20
First Post: 2017-02-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Trial of AZD2014 in TSC1/2 Mutated or TSC1/2 Null GC Patients as Second-line Chemotherapy
Sponsor: Samsung Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module